ArticleFrontiers in medicine2026
From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to identify novel risk factors for diabetic retinopathy (DR) and to explore whether phthalate exposure contribute to DR pathogenesis. Methods: We analyzed data from the 2017-2018 National Health and Nutrition Examination Survey (NHANES) and an independent clinical cohort using multiple feature-selection methods. To investigate the potential mechanisms of di-2-ethylhexyl phthalate (DEHP), we performed network toxicology and molecular docking analyes. Results: In NHANES, longer weekday outdoor time was associated with higher odds of DR (OR = 3.18, 95% CI: 1.36-7.95), whereas higher serum epi-25-hydroxyvitamin D3 levels were associated with lower odds of DR (OR = 0.80, 95% CI: 0.64-0.97). In the clinical cohort, less electronic device use was correlated with lower odds of DR (OR = 0.67, 95% CI: 0.43-0.98), while cataract was strongly associated with DR (OR = 11.0, 95% CI: 1.77-99.8). Urinary phthalate assessment showed inverse associations of mono-isobutyl phthalate (MiBP) and a mixed phthalate index with DR. Network toxicology identified 123 overlapping target genes, with enrichment in AGE-RAGE signaling and apoptosis-related pathways. Molecular docking predicted stable binding of MiBP to SRC, BCL2, and MAPK1. Conclusion: This integrative analysis identifies novel clinical and environmental correlates of DR and suggests a possible link between phthalate exposure and DR-related pathways. These findings highlight the potential relevance of environmental exposures in DR risk and offer a basis for further mechanistic and preventive research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.